AP2001002113A0 - Neuroimmunophilins for selective neuronal radioprotection. - Google Patents
Neuroimmunophilins for selective neuronal radioprotection.Info
- Publication number
- AP2001002113A0 AP2001002113A0 APAP/P/2001/002113A AP2001002113A AP2001002113A0 AP 2001002113 A0 AP2001002113 A0 AP 2001002113A0 AP 2001002113 A AP2001002113 A AP 2001002113A AP 2001002113 A0 AP2001002113 A0 AP 2001002113A0
- Authority
- AP
- ARIPO
- Prior art keywords
- neuroimmunophilins
- radioprotection
- selective neuronal
- ionizing radiation
- selectively protecting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1998/020040 WO2000016794A1 (fr) | 1998-09-23 | 1998-09-23 | Neuro-immunophillines pour radioprotection neuronale selective |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2001002113A0 true AP2001002113A0 (en) | 2001-06-30 |
Family
ID=22267931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/2001/002113A AP2001002113A0 (en) | 1998-09-23 | 1998-09-23 | Neuroimmunophilins for selective neuronal radioprotection. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1115412A4 (fr) |
JP (1) | JP2002526453A (fr) |
CN (1) | CN1322136A (fr) |
AP (1) | AP2001002113A0 (fr) |
AU (1) | AU766095B2 (fr) |
BR (1) | BR9816047A (fr) |
CA (1) | CA2345378A1 (fr) |
HK (1) | HK1040617A1 (fr) |
IL (1) | IL142120A0 (fr) |
WO (1) | WO2000016794A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE314084T1 (de) | 2000-10-31 | 2006-01-15 | Pharma Mar Sa | Kahalalid f formulierung |
WO2005103255A1 (fr) * | 2004-03-25 | 2005-11-03 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Recepteur formylpeptide (fpr) utilise en tant que cible pour une therapie anti-gliome malin |
US11745029B2 (en) | 2018-05-30 | 2023-09-05 | Zap Surgical Systems, Inc. | Radiosurgical neuromodulation close to critical structures |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE520730C2 (sv) * | 1995-01-20 | 2003-08-19 | Eskil Elmer | Behandling av hjärnischemi och hjärnskador med ett neuroprotektivt läkemedel |
JP3089350B2 (ja) * | 1995-11-20 | 2000-09-18 | ギルフォード ファーマシューティカルズ インコーポレイテッド | シクロフィリンロタマーゼ活性の阻害剤 |
-
1998
- 1998-09-23 CN CN98814297A patent/CN1322136A/zh active Pending
- 1998-09-23 IL IL14212098A patent/IL142120A0/xx unknown
- 1998-09-23 WO PCT/US1998/020040 patent/WO2000016794A1/fr not_active Application Discontinuation
- 1998-09-23 EP EP98948530A patent/EP1115412A4/fr not_active Withdrawn
- 1998-09-23 JP JP2000573755A patent/JP2002526453A/ja active Pending
- 1998-09-23 BR BR9816047-8A patent/BR9816047A/pt not_active Application Discontinuation
- 1998-09-23 CA CA002345378A patent/CA2345378A1/fr not_active Abandoned
- 1998-09-23 AP APAP/P/2001/002113A patent/AP2001002113A0/en unknown
- 1998-09-23 AU AU95081/98A patent/AU766095B2/en not_active Ceased
-
2002
- 2002-03-13 HK HK02101925.6A patent/HK1040617A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN1322136A (zh) | 2001-11-14 |
CA2345378A1 (fr) | 2000-03-30 |
AU9508198A (en) | 2000-04-10 |
IL142120A0 (en) | 2002-03-10 |
AU766095B2 (en) | 2003-10-09 |
HK1040617A1 (zh) | 2002-06-21 |
BR9816047A (pt) | 2003-01-07 |
JP2002526453A (ja) | 2002-08-20 |
EP1115412A4 (fr) | 2004-12-15 |
WO2000016794A1 (fr) | 2000-03-30 |
EP1115412A1 (fr) | 2001-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0859639A4 (fr) | Procedes de traitement de cancers et de la restenose a l'aide de p21 | |
DE69530272D1 (de) | Implantierbare Vorrichtung mit Schutzmitteln gegen elektromagnetische Störungen | |
HU9601870D0 (en) | Cryptographic system and method with key escrow feature | |
AU7686994A (en) | Investment fund management method and system | |
DE69227109D1 (de) | Durchsichtiges, uv absorbierendes sonnenschutzmittel und verfahren zu dessen herstellung | |
GB9405741D0 (en) | Semiconductor laser array device semiconductor laser device and production methods therefor | |
GB2352680B (en) | Anti counterfeit structure of passport and method for manufacturing the same | |
HK1040053B (zh) | 稠合吡咯並咔唑在預防/治療耳蝸毛細胞和耳蝸神經元損傷的用途 | |
ZA200003240B (en) | Connector for use in cathodic protection and method of use. | |
ZA94392B (en) | Internal radiation damage | |
GB2345361B (en) | Copy protection system and method | |
AU6549198A (en) | System and method for multi-level memory domain protection | |
EP0675543A3 (fr) | Dispositif semi-conducteur comprenant des moyens de protection et procédé de fabrication associé. | |
EP0640985A3 (fr) | Système d'alimentation négative distribuée pour grilles. | |
WO1998018440A3 (fr) | Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles | |
AU5173199A (en) | Method and device for authenticating with symmetrical algorithm | |
FR2676576B1 (fr) | Casque de protection et d'ecoute a audition orientee. | |
AP2001002113A0 (en) | Neuroimmunophilins for selective neuronal radioprotection. | |
GB2317111B (en) | Irradiation protection method | |
GB9408129D0 (en) | Water management and treatment systems | |
AU5819996A (en) | Topically applicable agents for treating and preventing alopecia | |
DE69421781D1 (de) | Garnitur zum Verbinden eines Energiekabels und damit ausgerüstetes Energiekabel | |
IL115020A0 (en) | Methods for inhibiting neuronal damage | |
AU3177893A (en) | Method for diagnosing and treating cancer | |
NO931347D0 (no) | Piperazin-derivat, fremgangsmaate for fremstilling, samt anvendelse |